INNOCAN PHARMA Corp
OTC: INNPF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Iris Bincovich
- Employees
- 11
- Headquarters
- Calgary, Canada
- IPO year
- 2020
- Market cap
- $9.4M
- Website
- https://innocanpharma.com
Loading INNPF…
Loading profile data…Frequently asked questions about INNPF
What does INNOCAN PHARMA Corp (INNPF) do?
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems by integrating cannabidiol (CBD) with diverse pharmaceutical ingredients. Its operations extend across the United States, Poland, France, and other international markets. The company actively pursues research and development into CBD-loaded ex...
Where does INNPF trade?
INNOCAN PHARMA Corp (INNPF) trades on the Other OTC.
What sector is INNPF in?
INNOCAN PHARMA Corp (INNPF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of INNOCAN PHARMA Corp?
Iris Bincovich is the chief executive officer of INNOCAN PHARMA Corp (INNPF).
Where is INNOCAN PHARMA Corp headquartered?
INNOCAN PHARMA Corp is headquartered in Canada.
Does INNPF pay a dividend?
INNOCAN PHARMA Corp (INNPF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did INNPF go public?
INNOCAN PHARMA Corp (INNPF) completed its initial public offering in 2020.